Description
There is mounting evidence that a significant source of COVID-19 infections has been through the environment —particularly aerosolized droplets from infected peoples' lungs. A solution is proposed whereby genome sequencing technologies will…
Amendment chain · 4 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $182,178 at start, $62,644 after amendment #4 (−$119,534).
- #02020-09-27$182,178
- #22021-02-10$92,417-$89,761
- #32021-09-27$111,627+$19,210
- #42021-12-21$62,644-$48,983
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2020-09-27(start date) | $182,178 | — | There is mounting evidence that a significant source of COVID-19 infections has been through the environment —… |
| #2 amendment | 2021-02-10 | $92,417 | −$89,761 | There is mounting evidence that a significant source of COVID-19 infections has been through the environment —… |
| #3 amendment | 2021-09-27 | $111,627 | +$19,210 | There is mounting evidence that a significant source of COVID-19 infections has been through the environment —… |
| #4 amendment | 2021-12-21 | $62,644 | −$48,983 | There is mounting evidence that a significant source of COVID-19 infections has been through the environment —… |
Related records · 9
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 840885594)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2026-2027-Q1-1041348 | National Research Council Canada | Conseil national de recherches Canada · CanExport | $20,500 | FY2027 |
| 172-2020-2021-Q1-948692 | National Research Council Canada | Conseil national de recherches Canada · CanExport SMEs | $18,750 | FY2021 |
| 172-2020-2021-Q1-950394 | National Research Council Canada | Conseil national de recherches Canada · Innovation Assistance Program | $132,132 | FY2021 |
| 276-2019-2020-Q4-00067 | Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique · REGI - Productivity and Business Skills | $48,750 | FY2020 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2020-2021-Q3-957543 · retrieved 2026-11-14.